On average, 4.9-fold down-regulation of neuropeptide Y receptor Y1 (NPY1R) was observed, which has been shown to inhibit the proliferation, migration and invasiveness of cancer cells (Lv X. et al., 2016; Li et al., 2020). The gene discussed is NPY1R; the disease is cancer.